Sopharma AD (SPH)
GPW
Real-time Data
07:00 AM
Day's Range
8.0052 wk Range
6.04Overview - SPH - Sopharma AD
Key Statistics
Valuation
Enterprise Value
20.40B
P/E (Trailing)
‪32.30‬
PEG Ratio
‪-0.43‬
Price / Sales (TTM)
‪3.17‬
Price / Book
‪8.49‬
EV / EBITDA
‪41.43‬
Profitability
Gross Margin
‪25.27%‬
Profit Margin
‪5.76%‬
Operating Margin
‪7.73%‬
Return on Assets
‪4.64%‬
Return on Equity
‪16.96%‬
Ownership
Shares Outstanding
528.43M
Float
168.41M
Held by Insiders
‪66.41%‬
Held by Institutions
‪0.17%‬
Price stats
Beta
‪0.08‬
50-Day Avg
‪7.59‬
200-Day Avg
‪9.33‬
Dividends
Payout Ratio
‪142.50%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - SPH - Sopharma AD
Peer Comparison
Compared with companies in Medical Distribution listed on GPW.
- SPHGPWSopharma AD4.43BMarket Cap-51.79%52-week change32.31P/E (Trailing)‪5.76%‬Profit Margin
- NEUGPWNeuca S.A.3.41BMarket Cap+12.70%52-week change20.20P/E (Trailing)‪1.26%‬Profit Margin
- NVGGPWNovavis Group S.A.24.16MMarket Cap-87.25%52-week change172.00P/E (Trailing)‪204.81%‬Profit Margin
Profile Summary - SPH - Sopharma AD
About
Sopharma AD is a diversified pharmaceutical company based in Bulgaria, engaging in the development, production, and distribution of pharmaceutical products. Its primary function is to manufacture a wide range of healthcare solutions, including over-the-counter (OTC) medicines, prescription drugs, and nutritional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
